Short and Long Term Clinical and Immunologic Follow up after Bone Marrow Mesenchymal Stromal Cell Therapy in Progressive Multiple Sclerosis—A Phase I Study
- Supplementary File 1:
PDF-Document (PDF, 122 KiB)
Iacobaeus, E.; Kadri, N.; Lefsihane, K.; Boberg, E.; Gavin, C.; Törnqvist Andrén, A.; Lilja, A.; Brundin, L.; Blanc, K.L. Short and Long Term Clinical and Immunologic Follow up after Bone Marrow Mesenchymal Stromal Cell Therapy in Progressive Multiple Sclerosis—A Phase I Study. J. Clin. Med. 2019, 8, 2102. https://doi.org/10.3390/jcm8122102
Iacobaeus E, Kadri N, Lefsihane K, Boberg E, Gavin C, Törnqvist Andrén A, Lilja A, Brundin L, Blanc KL. Short and Long Term Clinical and Immunologic Follow up after Bone Marrow Mesenchymal Stromal Cell Therapy in Progressive Multiple Sclerosis—A Phase I Study. Journal of Clinical Medicine. 2019; 8(12):2102. https://doi.org/10.3390/jcm8122102
Chicago/Turabian StyleIacobaeus, Ellen; Kadri, Nadir; Lefsihane, Katia; Boberg, Erik; Gavin, Caroline; Törnqvist Andrén, Anton; Lilja, Anders; Brundin, Lou; Blanc, Katarina L. 2019. "Short and Long Term Clinical and Immunologic Follow up after Bone Marrow Mesenchymal Stromal Cell Therapy in Progressive Multiple Sclerosis—A Phase I Study" J. Clin. Med. 8, no. 12: 2102. https://doi.org/10.3390/jcm8122102